XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Restructuring Activities (Notes) | 9 Months Ended
--- | ---
Sep. 30, 2017
Restructuring and Related Activities [Abstract] |
Restructuring and Related Activities Disclosure [Text Block] | Restructuring Activities The Company has implemented a number of cost reduction or avoidance actions, including headcount reductions and facility closures and relocations primarily relating to the consolidation of certain of our facilities in China, the Buffalo BioMedical respiratory consolidation, and relocation of the corporate headquarters. The Buffalo Biomedical respiratory facility consolidation into Ball Ground, Georgia, was completed during the first quarter of 2017. The E&C Wuxi, China facility consolidation was completed during the second quarter of 2017, and the D&S China facility consolidation is expected to be completed by the end of 2017. Our corporate headquarters move from Garfield Heights, Ohio to Ball Ground, Georgia (which was official effective October 26, 2017) was substantially completed during the third quarter of 2017, and the Company’s Garfield Heights headquarters lease commitment ends December 31, 2017. The following table is a summary of the severance and other restructuring costs, which included employee-related costs, facility rent and exit costs, relocation, recruiting, travel and other, for the three months and nine months ended September 30, 2017 and 2016:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2017 |  | 2016 |  | 2017 |  | 2016
Severance: |  |  |  |  |  |  |
Cost of sales | $ | 52 |  |  | $ | 159 |  |  | $ | 731 |  |  | $ | 3,501 |
Selling, general, and administrative expenses | 920 |  |  | 43 |  |  | 2,767 |  |  | 2,382 |
Total severance costs | $ | 972 |  |  | $ | 202 |  |  | $ | 3,498 |  |  | $ | 5,883 |
Other restructuring: |  |  |  |  |  |  |
Cost of sales | $ | 278 |  |  | $ | — |  |  | $ | 4,072 |  |  | $ | — |
Selling, general, and administrative expenses | 1,499 |  |  | 103 |  |  | 4,847 |  |  | 420 |
Total other restructuring costs | $ | 1,777 |  |  | $ | 103 |  |  | $ | 8,919 |  |  | $ | 420 |
Total restructuring costs | $ | 2,749 |  |  | $ | 305 |  |  | $ | 12,417 |  |  | $ | 6,303 |
The Company is closely monitoring its end markets and order rates and will continue to take appropriate and timely actions as necessary. The Company currently expects additional restructuring costs in the remaining three months of 2017 to be approximately $1,530 ($1,000 - D&S, $310 - BioMedical, and $220 - Corporate), but further actions may be required based on future business conditions. The following tables summarize the Company’s restructuring activities for the three and nine months ended September 30, 2017 and 2016:
| Three Months Ended September 30, 2017
| Energy & Chemicals |  | Distribution & Storage |  | BioMedical |  | Corporate |  | Total
Balance as of June 30, 2017 | $ | — |  |  | $ | 1,865 |  |  | $ | 847 |  |  | $ | 1,493 |  |  | $ | 4,205 |
Restructuring costs | 162 |  |  | 648 |  |  | 516 |  |  | 1,423 |  |  | 2,749 |
Cash payments | (157 | ) |  | (1,381 | ) |  | (803 | ) |  | (1,480 | ) |  | (3,821 | )
Acquired restructuring reserve | 194 |  |  | — |  |  | — |  |  | — |  |  | 194 |
Balance as of September 30, 2017 | $ | 199 |  |  | $ | 1,132 |  |  | $ | 560 |  |  | $ | 1,436 |  |  | $ | 3,327 |
| Three Months Ended September 30, 2016
| Energy & Chemicals |  | Distribution & Storage |  | BioMedical |  | Corporate |  | Total
Balance as of June 30, 2016 | $ | 544 |  |  | $ | 4,796 |  |  | $ | 368 |  |  | $ | 276 |  |  | $ | 5,984 |
Restructuring costs | 159 |  |  | 118 |  |  | — |  |  | 28 |  |  | 305 |
Cash payments | (267 | ) |  | (1,160 | ) |  | (168 | ) |  | (219 | ) |  | (1,814 | )
Balance as of September 30, 2016 | $ | 436 |  |  | $ | 3,754 |  |  | $ | 200 |  |  | $ | 85 |  |  | $ | 4,475 |
| Nine Months Ended September 30, 2017
| Energy & Chemicals |  | Distribution & Storage |  | BioMedical |  | Corporate |  | Total
Balance as of December 31, 2016 | $ | 127 |  |  | $ | 2,864 |  |  | $ | 1,308 |  |  | $ | 3,025 |  |  | $ | 7,324 |
Restructuring costs | 2,245 |  |  | 1,085 |  |  | 4,527 |  |  | 4,560 |  |  | 12,417 |
Cash payments | (2,367 | ) |  | (2,817 | ) |  | (5,275 | ) |  | (6,149 | ) |  | (16,608 | )
Acquired restructuring reserve | 194 |  |  | — |  |  | — |  |  | — |  |  | 194 |
Balance as of September 30, 2017 | $ | 199 |  |  | $ | 1,132 |  |  | $ | 560 |  |  | $ | 1,436 |  |  | $ | 3,327 |
| Nine Months Ended September 30, 2016
| Energy & Chemicals |  | Distribution & Storage |  | BioMedical |  | Corporate |  | Total
Balance as of December 31, 2015 | $ | 1,106 |  |  | $ | 3,446 |  |  | $ | 430 |  |  | $ | 850 |  |  | $ | 5,832 |
Restructuring costs | 821 |  |  | 3,929 |  |  | 521 |  |  | 1,032 |  |  | 6,303 |
Cash payments | (1,491 | ) |  | (3,621 | ) |  | (751 | ) |  | (1,797 | ) |  | (7,660 | )
Balance as of September 30, 2016 | $ | 436 |  |  | $ | 3,754 |  |  | $ | 200 |  |  | $ | 85 |  |  | $ | 4,475 |

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4) -URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 5.P.3) -URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration